Intestinal activation of LXRα may protect against hepatic steatosis by promoting the restoration of liver triglyceride content through modifications in the hepatic expression of genes involved in lipid synthesis, storage, and uptake. This evidence concerns the gene NR1H3 and fatty liver disease.